The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.
Global Gene Vector Market Report By Vector Type (Lentivirus, Adenovirus, Adeno-associated Virus (AAV), Plasmid DNA, Others), By Application (Gene Therapy, Vaccinology, Others), By Disease (Genetic Disorder, Cancer, Infectious Disease, Others), By End-user (Scientific Research, CRO, CDMO, Others (Pharmaceutical, Biotechnology Companies)) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028
ID:VMR11220627
March 2023
Report Formats: Electronic (PDF), MS EXCEL
The global demand for Gene Vector Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
A gene vector is a tool used to transfer genetic material into cells, tissues, or organs in order to alter or replace their genetic makeup. Gene vectors are commonly used in genetic engineering, gene therapy, and biotechnology research. There are several types of gene vectors, including viral and non-viral vectors. Viral vectors are derived from viruses and can be used to deliver genetic material to cells in a highly efficient manner. Examples of viral vectors include retroviruses, adenoviruses, and lentiviruses. Non-viral vectors, on the other hand, are typically made from DNA or RNA and are less efficient than viral vectors. Examples of non-viral vectors include plasmids, liposomes, and nanoparticles. Gene vectors are used in a wide range of applications, including gene therapy, where they are used to deliver healthy genes to cells in order to treat genetic diseases. They are also used in research to study gene function, create transgenic organisms, and develop new biotechnology products.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gene vector. The growth and trends of gene vector industry provide a holistic approach to this study.
By Vector Type
By Application
By Disease
By End-User
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gene vector market include Lonza, Merck KGaA, Oxford Biomedica, CGT Catapult, Charles River Laboratories, uniQure N.V., FUJIFILM Diosynth Biotechnologies, Spark Therapeutics, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
A gene vector is a tool used to transfer genetic material into cells, tissues, or organs in order to alter or replace their genetic makeup. Gene vectors are commonly used in genetic engineering, gene therapy, and biotechnology research. There are several types of gene vectors, including viral and non-viral vectors. Viral vectors are derived from viruses and can be used to deliver genetic material to cells in a highly efficient manner. Examples of viral vectors include retroviruses, adenoviruses, and lentiviruses. Non-viral vectors, on the other hand, are typically made from DNA or RNA and are less efficient than viral vectors. Examples of non-viral vectors include plasmids, liposomes, and nanoparticles. Gene vectors are used in a wide range of applications, including gene therapy, where they are used to deliver healthy genes to cells in order to treat genetic diseases. They are also used in research to study gene function, create transgenic organisms, and develop new biotechnology products.
Market Dynamics
The rising incidence of genetic disorders, such as cancer, cystic fibrosis, and sickle cell anaemia, is driving the demand for gene vectors. Gene vectors are used in gene therapy, a promising approach for treating genetic disorders by delivering healthy genes to cells. Ongoing advancements in gene therapy technology, such as the development of safer and more efficient gene vectors, are driving the growth of the gene vector market. This includes the use of viral vectors, such as lentiviruses and adeno-associated viruses, which have improved safety and efficacy profiles. There is a significant amount of investment being made in gene therapy research by governments, private companies, and research institutions. This is driving the development of new gene therapies and the use of gene vectors as key tools in their delivery. Personalized medicine, which involves tailoring treatment to an individual's specific genetic makeup, is a growing trend in healthcare. Gene vectors are a critical tool in delivering personalized medicine, which is driving their adoption. There is increasing awareness and acceptance of gene therapy among patients, healthcare providers, and regulatory bodies. This is driving the adoption of gene vectors as a key tool in gene therapy.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gene vector. The growth and trends of gene vector industry provide a holistic approach to this study.
Market Segmentation
This section of the gene vector market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.By Vector Type
- Lentivirus
- Adenovirus
- Adeno-Associated Virus (AAV)
- Plasmid DNA
- Others
By Application
- Gene Therapy
- Vaccinology
- Others
By Disease
- Genetic Disorder
- Cancer
- Infectious Disease
- Others
By End-User
- Scientific Research
- CRO
- CDMO
- Others (Pharmaceutical, Biotechnology Companies)
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Gene Vector market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.Global Gene Vector Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gene vector market include Lonza, Merck KGaA, Oxford Biomedica, CGT Catapult, Charles River Laboratories, uniQure N.V., FUJIFILM Diosynth Biotechnologies, Spark Therapeutics, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . GENE VECTOR – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Vector Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Disease
3.7.4 Market Attractiveness Analysis By End-user
3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL GENE VECTOR MARKET ANALYSIS BY VECTOR TYPE
6.1 Overview by Vector Type
6.2 Historical and Forecast Data
6.3 Analysis by Vector Type
6.4 Lentivirus Historic and Forecast Sales by Regions
6.5 Adenovirus Historic and Forecast Sales by Regions
6.6 Adeno-associated Virus (AAV) Historic and Forecast Sales by Regions
6.7 Plasmid DNA Historic and Forecast Sales by Regions
6.8 Others Historic and Forecast Sales by Regions
7 . GLOBAL GENE VECTOR MARKET ANALYSIS BY APPLICATION
7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Gene Therapy Historic and Forecast Sales by Regions
7.5 Vaccinology Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions
8 . GLOBAL GENE VECTOR MARKET ANALYSIS BY DISEASE
8.1 Overview by Disease
8.2 Historical and Forecast Data
8.3 Analysis by Disease
8.4 Genetic Disorder Historic and Forecast Sales by Regions
8.5 Cancer Historic and Forecast Sales by Regions
8.6 Infectious Disease Historic and Forecast Sales by Regions
8.7 Others Historic and Forecast Sales by Regions
9 . GLOBAL GENE VECTOR MARKET ANALYSIS BY END-USER
9.1 Overview by End-user
9.2 Historical and Forecast Data
9.3 Analysis by End-user
9.4 Scientific Research Historic and Forecast Sales by Regions
9.5 CRO Historic and Forecast Sales by Regions
9.6 CDMO Historic and Forecast Sales by Regions
9.7 Others (Pharmaceutical, Biotechnology Companies) Historic and Forecast Sales by Regions
10 . GLOBAL GENE VECTOR MARKET ANALYSIS BY GEOGRAPHY
10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
10.3.1. Overview, Historic and Forecast Sales Analysis
10.3.2. North America By Segment Sales Analysis
10.3.3. North America By Country Sales Analysis
10.3.4. United State Sales Analysis
10.3.5. Canada Sales Analysis
10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
10.4.1. Overview, Historic and Forecast Sales Analysis
10.4.2. Europe by Segment Sales Analysis
10.4.3. Europe by Country Sales Analysis
10.4.4. United Kingdom Sales Analysis
10.4.5. France Sales Analysis
10.4.6. Germany Sales Analysis
10.4.7. Italy Sales Analysis
10.4.8. Russia Sales Analysis
10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
10.5.1. Overview, Historic and Forecast Sales Analysis
10.5.2. Asia Pacific by Segment Sales Analysis
10.5.3. Asia Pacific by Country Sales Analysis
10.5.4. China Sales Analysis
10.5.5. India Sales Analysis
10.5.6. Japan Sales Analysis
10.5.7. South Korea Sales Analysis
10.5.8. Australia Sales Analysis
10.5.9. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
10.6.1. Overview, Historic and Forecast Sales Analysis
10.6.2. Latin America by Segment Sales Analysis
10.6.3. Latin America by Country Sales Analysis
10.6.4. Brazil Sales Analysis
10.6.5. Argentina Sales Analysis
10.6.6. Peru Sales Analysis
10.6.7. Chile Sales Analysis
10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
10.7.1. Overview, Historic and Forecast Sales Analysis
10.7.2. Middle East & Africa by Segment Sales Analysis
10.7.3. Middle East & Africa by Country Sales Analysis
10.7.4. Saudi Arabia Sales Analysis
10.7.5. UAE Sales Analysis
10.7.6. Israel Sales Analysis
10.7.7. South Africa Sales Analysis
10.7.8. Rest Of Middle East And Africa Sales Analysis
11 . COMPETITIVE LANDSCAPE OF THE GENE VECTOR COMPANIES
11.1. Gene Vector Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments
12 . COMPANY PROFILES OF GENE VECTOR INDUSTRY
12.1. Top Company Share Analysis
12.2. Market Concentration Rate
12.3. Lonza
12.3.1. Company Overview
12.3.2. Company Revenue
12.3.3. Products
12.3.4. Recent Developments
12.4. Merck KGaA
12.4.1. Company Overview
12.4.2. Company Revenue
12.4.3. Products
12.4.4. Recent Developments
12.5. Oxford Biomedica
12.5.1. Company Overview
12.5.2. Company Revenue
12.5.3. Products
12.5.4. Recent Developments
12.6. CGT Catapult
12.6.1. Company Overview
12.6.2. Company Revenue
12.6.3. Products
12.6.4. Recent Developments
12.7. Charles River Laboratories
12.7.1. Company Overview
12.7.2. Company Revenue
12.7.3. Products
12.7.4. Recent Developments
12.8. uniQure N.V.
12.8.1. Company Overview
12.8.2. Company Revenue
12.8.3. Products
12.8.4. Recent Developments
12.9. FUJIFILM Diosynth Biotechnologies
12.9.1. Company Overview
12.9.2. Company Revenue
12.9.3. Products
12.9.4. Recent Developments
12.10. Spark Therapeutics Inc.
12.10.1. Company Overview
12.10.2. Company Revenue
12.10.3. Products
12.10.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Vector Type (USD MN)
- Lentivirus Market Sales by Geography (USD MN)
- Adenovirus Market Sales by Geography (USD MN)
- Adeno-associated Virus (AAV) Market Sales by Geography (USD MN)
- Plasmid DNA Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis Market by Application (USD MN)
- Gene Therapy Market Sales by Geography (USD MN)
- Vaccinology Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis by Disease (USD MN)
- Genetic Disorder Market Sales by Geography (USD MN)
- Cancer Market Sales by Geography (USD MN)
- Infectious Disease Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis by End-user (USD MN)
- Scientific Research Market Sales by Geography (USD MN)
- CRO Market Sales by Geography (USD MN)
- CDMO Market Sales by Geography (USD MN)
- Others (Pharmaceutical, Biotechnology Companies) Market Sales by Geography (USD MN)
- Global Gene Vector Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Gene Vector Report
- Market Research Process
- Market Research Methodology
- Global Gene Vector Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Vector Type
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by Disease
- Market Attractiveness Analysis by End-user
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Vector Type (USD MN)
- Lentivirus Market Sales by Geography (USD MN)
- Adenovirus Market Sales by Geography (USD MN)
- Adeno-associated Virus (AAV) Market Sales by Geography (USD MN)
- Plasmid DNA Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Gene Therapy Market Sales by Geography (USD MN)
- Vaccinology Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by Disease (USD MN)
- Genetic Disorder Market Sales by Geography (USD MN)
- Cancer Market Sales by Geography (USD MN)
- Infectious Disease Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by End-user (USD MN)
- Scientific Research Market Sales by Geography (USD MN)
- CRO Market Sales by Geography (USD MN)
- CDMO Market Sales by Geography (USD MN)
- Others (Pharmaceutical, Biotechnology Companies) Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Company Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Related Categories
Biotechnology
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments